IM PD Bio-Therapeutics Technical Lead at Johnson & Johnson

Schaffhausen, Schaffhausen, Switzerland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Industry-leading expertise as a Subject Matter Expert (SME) in Innovative Medicines (IM) Project Delivery, particularly in Bio-Therapeutics for Drug Substance and Drug Product facilities
Profound knowledge of facility design, construction, commissioning, and process validation for green field and brown field projects
Ability to provide overarching technical leadership and guidance in engineering for capital projects from concept to handover
Up-to-date knowledge of current industry and regulatory standards, trends, 483s, and audit reports

Responsibilities

Provide expert engineering technical support and guidance in facility business needs, design, construction, commissioning, and process validation for strategic Drug Substance and Drug Product facilities
Define and deploy a vision and strategy for standard Facility and Equipment design across all IM capital projects
Oversee the design and creation of all necessary Facility and Equipment processes and standards to ensure safe, compliant, and reliable transition from project build to start-up, operations, and maintenance
Keep abreast of all current industry and regulatory standards and trends (e.g., 483s, audit reports) to ensure IM Bio-Therapeutics manufacturing plants are designed, built, and commissioned to leading-edge standards
Work across project teams and end-state site engineering teams to ensure integration, close collaboration, and seamless handover from project to operations

Skills

Project Engineering

Supply Chain Engineering

Technical Leadership

ATMP

Bio-Therapeutics

Engineering Services

Strategic Project Delivery

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters

1886Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.

Former J&J executives joining other firms could lead to increased competition.

Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.

The company invests heavily in R&D for innovative medical solutions and products.

J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.

The rise of personalized medicine offers J&J opportunities in targeted therapies.

Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI

Try Jobo Free